Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to have our next session with Integra LifeSciences, bringing up Jan De Witte, the new CEO for a presentation, and then we'll do some questions and answers.
Okay. Thank you, Robbie. As he said, I'm Jan de Witte, still a relatively fresh new CEO of Integra LifeSciences. I'm here with Carrie Anderson, our CFO. She's going to join me up here for the Q&A together with Robbie after.
But first things first, our safe harbor disclosure reminded that some of the statements I'll be making are forward-looking.
But let's get started. I think that many of you here in the room or on the webcast follow Integra for several years. I do hope that there are some people who do not know Integra that well and come away after this presentation as excited as I am about the potential of Integra LifeSciences.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
